title: Implications of the ADEMEX trial.
authors.affiliation: Renal Division, Baxter Healthcare Corporation, McGaw Park, Ill., USA. salim_mujais@baxter.com
authors.forename: Salim
authors.initials: S
authors.lastname: Mujais
authors.forename: Edward
authors.initials: E
authors.lastname: Vonesh
authors.forename: Ali
authors.initials: A
authors.lastname: Abu-Alfa
mesh_terms: D018849:Controlled Clinical Trials as Topic; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D010530:Peritoneal Dialysis / Q000592:standards*; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis / Q000592:standards; D017749:Total Quality Management; D014481:United States